Neurones S.A. (EPA:NRO)
France · Delayed Price · Currency is EUR 40.55
-0.05 (-0.12%)
Nov 11, 2026, 5:35 PM CET
Neurones Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 967 | 1,047 | 1,067 | 1,062 | 951 | 920 | |
Market Cap Growth | -6.44% | -1.89% | 0.46% | 11.68% | 3.32% | 62.40% |
Enterprise Value | 764 | 860 | 895 | 885 | 794 | 762 |
Last Close Price | 40.55 | 41.43 | 41.13 | 39.85 | 34.81 | 32.79 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 17.78 | 20.10 | 20.30 | 21.49 | 21.49 | 24.41 |
Forward PE | 17.41 | 18.89 | 21.08 | 20.73 | 19.54 | 22.28 |
PS Ratio | 1.09 | 1.22 | 1.32 | 1.43 | 1.43 | 1.59 |
PB Ratio | 2.23 | 2.25 | 2.45 | 2.59 | 2.53 | 2.61 |
P/TBV Ratio | 3.08 | 3.10 | 3.34 | 3.53 | 3.34 | 3.46 |
P/FCF Ratio | 12.21 | 17.20 | 14.75 | 19.63 | 21.43 | 15.89 |
P/OCF Ratio | 10.58 | 14.68 | 12.64 | 14.73 | 17.30 | 14.27 |
PEG Ratio | - | 1.45 | 1.45 | 1.45 | 1.45 | 1.45 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.86 | 1.00 | 1.10 | 1.19 | 1.19 | 1.31 |
EV/EBITDA Ratio | 7.57 | 9.88 | 10.24 | 10.70 | 9.98 | 10.98 |
EV/EBIT Ratio | 9.33 | 11.38 | 11.50 | 11.85 | 10.99 | 12.36 |
EV/FCF Ratio | 9.65 | 14.13 | 12.37 | 16.36 | 17.90 | 13.16 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.10 | 0.10 | 0.12 | 0.11 | 0.10 | 0.10 |
Debt / EBITDA Ratio | 0.41 | 0.49 | 0.55 | 0.49 | 0.41 | 0.46 |
Debt / FCF Ratio | 0.53 | 0.77 | 0.73 | 0.81 | 0.80 | 0.61 |
Net Debt / Equity Ratio | -0.60 | -0.63 | -0.63 | -0.62 | -0.63 | -0.65 |
Net Debt / EBITDA Ratio | -2.78 | -3.38 | -3.13 | -3.07 | -2.97 | -3.31 |
Net Debt / FCF Ratio | -3.28 | -4.83 | -3.78 | -4.69 | -5.33 | -3.97 |
Asset Turnover | 1.23 | 1.16 | 1.16 | 1.15 | 1.12 | 1.04 |
Inventory Turnover | 40667.36 | 3079.37 | 863.92 | 742.79 | 574.62 | 424.84 |
Quick Ratio | 2.16 | 2.36 | 2.26 | 2.33 | 2.40 | 2.46 |
Current Ratio | 2.23 | 2.43 | 2.33 | 2.38 | 2.45 | 2.52 |
Return on Equity (ROE) | 15.32% | 13.73% | 14.95% | 14.92% | 14.21% | 12.06% |
Return on Assets (ROA) | 7.07% | 6.41% | 6.94% | 7.22% | 7.63% | 6.89% |
Return on Invested Capital (ROIC) | 34.20% | 32.95% | 35.06% | 36.72% | 39.15% | 34.33% |
Return on Capital Employed (ROCE) | 17.50% | 15.10% | 16.50% | 16.70% | 17.70% | 16.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 5.62% | 4.98% | 4.93% | 4.65% | 4.65% | 4.10% |
FCF Yield | 8.19% | 5.81% | 6.78% | 5.09% | 4.67% | 6.29% |
Dividend Yield | 3.45% | 3.25% | 2.96% | 2.74% | 2.80% | 2.63% |
Payout Ratio | 60.45% | 60.73% | 55.42% | 53.93% | 54.75% | - |
Buyback Yield / Dilution | 0.28% | -0.13% | -0.14% | -0.10% | -0.18% | 0.13% |
Total Shareholder Return | 3.73% | 3.12% | 2.82% | 2.65% | 2.63% | 2.76% |